
IMMATICS NV- WARRANTS
Acción · NL0015285958 · IMTXW (XNAS)
0,03 USD
09.06.2025 18:44
Cotizaciones actuales de IMMATICS NV- WARRANTS
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
IMTXW
|
USD
|
09.06.2025 18:44
|
0,03 USD
| 0,03 USD
+9,60 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | 1,49 % | 97,12 % | -16,62 % | -93,48 % | -99,26 % | -99,50 % |
Perfil de la empresa para IMMATICS NV- WARRANTS Acción
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.
Datos de la empresa
Nombre IMMATICS NV- WARRANTS
Empresa immatics biotechnologies GmbH
Símbolo IMTXW
Sitio web
https://www.immatics.com
Mercado principal
NASDAQ

ISIN NL0015285958
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Dr. Harpreet Singh Ph.D.
Capitalización de mercado 387 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,6 T
Dirección Paul-Ehrlich-Strasse 15, 72076 Tübingen
Fecha de OPV 2020-07-02
Símbolos de cotización
Nombre | Símbolo |
---|---|
NASDAQ | IMTXW |
Otras acciones
Los inversores que tienen IMMATICS NV- WARRANTS también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.